Study Completed

Female contraception

Bayer Identifier:

13140

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2008-002052-23

EU CT Number:

Not Available

DRSP wafer: rel. BA vs. Yaz

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

45 - 75 Years

Trial summary

Enrollment Goal

Trial Dates

March 2009 - June 2009

Phase

Phase 1

Could I Receive a placebo

N/A

Products

DRSP Ring (BAY86-4888)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Terminated	Scope International	Hamburg, 22525, Germany
Completed	Bayer Pharma AG	Berlin, 13353, Germany

Trial design

An open-label, single-dose, randomized, 3-fold crossover study investigating the relative bioavailability of drospirenone (DRSP) and ethinylestradiol (EE) after oral single dose administrations of 3 mg DRSP and 0.02 mg EE as two different wafer formulations versus as a marketed tablet in 18 healthy postmenopausal women

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.